Onyia Jude
- SEC CIK
- 0001894425
In the past year, 2 open-market sale filings worth $3.47M and no purchases.
Current role at each company
- NBIX Neurocrine Biosciences IncChief Scientific Officeras of Sep 15, 2026
- VYGR Voyager Therapeutics, Inc.Directoras of Jun 11, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.47M
- 2 filings
- Net
- −$3.47M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Onyia Jude as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NBIX Neurocrine Biosciences Inc
Chief Scientific Officer14 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 (view filing) | Nov 29 | 2 days | Onyia JudeChief Scientific Officer | SSale | −2.33K | $121.90 | −$284.1K | −49.6%2.37K after | |
| Feb 2, 2023 (view filing) | Jan 31 | 2 days | Onyia JudeChief Scientific Officer | SSale | −126 | $108.48 | −$13.7K | −4.8%2.48K after | |
| Feb 8, 2023 (view filing) | Feb 7 | 1 day | Onyia JudeChief Scientific Officer | SSale | −4.51K | $102.30 | −$461.2K | −40.9%6.53K after | |
| Aug 23, 2023 (view filing) | Aug 21 | 2 days | Onyia JudeChief Scientific Officer | SSale | −3.20K | $107.37 | −$343.4K | −24.9%9.64K after | 10b5-1 |
| Dec 1, 2023 (view filing) | Nov 29 | 2 days | Onyia JudeChief Scientific Officer | SSale | −2.33K | $113.57 | −$264.7K | −16.6%11.7K after | 10b5-1 |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Onyia JudeChief Scientific Officer | SSale | −126 | $141.94 | −$17.9K | −1.1%11.8K after | 10b5-1 |
| Feb 15, 2024 (view filing) | Feb 13 | 2 days | Onyia JudeChief Scientific Officer | SSale | −1.43K | $132.94 | −$190.4K | −9.8%13.1K after | 10b5-1 |
| Dec 3, 2024 (view filing) | Nov 29 | 4 days | Onyia JudeChief Scientific Officer | SSale | −2.33K | $126.29 | −$294.4K | −13.1%15.4K after | 10b5-1 |
| Feb 4, 2025 (view filing) | Jan 31 | 4 days | Onyia JudeChief Scientific Officer | SSale | −126 | $152.97 | −$19.3K | −0.8%15.6K after | 10b5-1 |
| Feb 14, 2025 (view filing) | Feb 13 | 1 day | Onyia JudeChief Scientific Officer | SSale | −2.88K | $116.79 | −$336.2K | −13.7%18.1K after | 2 lots10b5-1 |